Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

TZD drug pioglitazone becomes second-ever diabetes drug to reduce heart disease and first to reduce strokes. Who might this benefit most?
Combining metformin and Jardiance into a single pill.
Will this drug be cheaper than Lantus and other insulins?
What did four diabetes experts say was the most promising future innovation in diabetes?
The two organizations expand their research partnership to support glucose responsive insulin.
Clinical trial currently enrolling for type 2 diabetes – find out if you qualify for this study.
Goal to maintain access to therapy over next six months. What challenges have been seen to date?
Currently recruiting in people newly diagnosed with type 1.
Breaking news from Stockholm, Sweden, where our team is on the ground at the European Association for the Study of Diabetes (EASD) Conference – one of the largest...
IBM and Medtronic announce the first product out of their innovative partnership.
Zosano Pharma is making early progress with an innovative patch-based glucagon delivery system for severe hypoglycemia, recently announcing that it has completed...
When might this product reach the market?
Smartphone user interface with no screen or buttons on the pump! Launch: 2018?
And “potentially transformative” advances coming for type 1 diabetes.
New trial testing the inhaled, ultra-rapid insulin in 4-17 year olds.
Flat insulin allows for flexible dosing with lower likelihood of hypoglycemia. How is it priced vs. Levemir?
Praluent now approved for two specific patient populations. How this drug has the future potential to make a big impact on people with diabetes.
Gamechanging Xultophy (Tresiba + Victoza) also now submitted to the FDA.
Launch before the second half of 2016. What savings program will be offered?
Today, Lilly/BI announced first-ever news in diabetes: a major clinical trial on Jardiance , an SGLT-2 inhibitor pill for type 2 diabetes, has been proven to improve...